Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542101 | SCV000627209 | pathogenic | Osteogenesis imperfecta type I | 2025-01-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg882*) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with osteogenesis imperfecta type I (PMID: 15241796, 21667357, 22753364, 26627451, 27044453). ClinVar contains an entry for this variant (Variation ID: 456753). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000578858 | SCV000680708 | pathogenic | not provided | 2023-11-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26627451, 31414283, 25533962, 21667357, 16786509, 22753364, 30614853, 27044453, 33939306, 33166682, 35476365, 15241796) |
Revvity Omics, |
RCV000578858 | SCV002017429 | pathogenic | not provided | 2020-06-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279330 | SCV002565164 | pathogenic | Osteogenesis imperfecta | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001535522 | SCV001749485 | not provided | Ehlers-Danlos syndrome, arthrochalasia type; Osteogenesis imperfecta | no assertion provided | phenotyping only | Variant interpreted as Pathogenic and reported on 08-03-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. | |
Human Development and Health, |
RCV000578858 | SCV002106372 | not provided | not provided | no assertion provided | in vitro |